جستجوی استاد راهنمای دانشگاهی

Katja Hose is a Full Professor of Data Management at TU Wien's DBAI research unit, heading the Data Management and Knowledge-Driven AI Lab. She previously held a Poul Due Jensen Foundation Professorship at Aalborg University. Her research focuses on data and knowledge engineering, including graph databases, knowledge graphs, querying, analytics, and machine learning, with interdisciplinary applications in bioscience, healthcare, and environmental assessment. Education: PhD in Computer Science (Ilmenau University of Technology, 2009), Postdoc at Max Planck Institute for Informatics (2009–2012). Academic roles include Program Co-Chair for ISWC 2024 and EDBT 2023, and editorial board membership at VLDBJ and TGDK. She leads projects like TARGET (health virtual twins) and ARMADA (data management). Research Interests: Knowledge Graphs, Semantic Web, Big Data, Machine Learning, Data Integration, and Provenance Systems. Key contributions include SHACL shape extraction, conversational data analytics, and environmental knowledge graphs. Awards include the 2025 Distinguished Meta-Reviewer Award and 2024 Manfred Paul Award. Advising and Grants: Supervised students including E. Pürmayr (Diploma Thesis 2025). Active in EU projects (TARGET, ARMADA) and grant coordination. Labs/Teams: DMKI Lab at TU Wien, collaborating with interdisciplinary teams in healthcare and environmental science.

• Knowledge Graphs
• Semantic Web
• Data Management
• +۷ مورد دیگر

Professor Carlo Pappone is a Full Professor of Cardiology at Vita-Salute San Raffaele University (since 2019) and Director of the Arrhythmology Department at IRCCS Policlinico San Donato Hospital (since 2015). He has held previous academic/clinical leadership roles at IRCCS San Raffaele Hospital (2000-2010), Villa Maria Cecilia Hospital (2010-2015), and University of Naples Federico II (1990-2000). With 212 publications in top journals like NEJM, JAMA, and Circulation, he has made significant contributions to cardiac arrhythmia research. Current Positions Vita-Salute San Raffaele University (2019-present): Full Professor of Cardiology IRCCS Policlinico San Donato Hospital (2015-present): Director of Arrhythmology Department Previous Roles University of Naples Federico II (1990-2000) University of Michigan Ann Harbor (1990-2000) IRCCS San Raffaele Hospital (2000-2010) Villa Maria Cecilia Hospital (2010-2015) Research Focus: Specializing in cardiovascular diseases, his work spans atrial fibrillation ablation techniques, Brugada syndrome pathogenesis, heart failure device therapy, and ion channel disorders. His H-index of 53 and 18,407 citations reflect his substantial academic impact. Notable Scientific Contributions Author of 44 patents Principal Investigator in 14 clinical trials (clinicaltrials.gov) Developed circumferential pulmonary vein ablation technique Innovator in biventricular pacing systems for heart failure Pioneered research on non-excitatory current for cardiac contractility Scientific Recognition Awarded as Elite Reviewer of JACC (2005) Editorial Board Member of 6 leading journals Reviewer for NEJM, JAMA, Lancet, and Nature Medicine Education Medical Doctorate: University of Naples Federico II

• Cardiology
• Electrophysiology
• Cardiac Arrhythmias
• +۴ مورد دیگر

Professor Patricia Connolly serves in the Department of Biomedical Engineering within the Faculty of Engineering at the University of Strathclyde, United Kingdom. Her research directly contributes to UN Sustainable Development Goals through biomedical innovation. Her research spans wound monitoring systems , engineered biomaterials (particularly silk-based surgical solutions), and digital health technologies . Key focus areas include: Non-invasive physiological monitoring devices Iontophoresis and transdermal drug delivery Surgical wound healing biomaterials mHealth interventions for cardiac conditions Digital twin applications in surgery Her recent publications reveal strong trends in merging real-time physiological data with surgical decision support systems , particularly through digital twin technology and biomaterial innovation for wound care. Award highlights: Real-time Digital Twin Assisted Surgery (DTAS) award (2023) Professor Connolly actively supervises postgraduate research (8 students documented) and secures major grants including Wellcome Trust and Medical Research Scotland funding. Her current projects span wound monitoring systems, engineered silks for surgical applications, and collaborative research cultures. She operates within Strathclyde's Biomedical Engineering facilities, utilizing advanced equipment including the Metrohm Autolab PGSTAT302N Potentiostat for electrochemical analysis in wound monitoring research.

• Biomedical Engineering
• Wound Care
• Medical Devices
• +۵ مورد دیگر

Dr. Guangyao Li is a Research Fellow in the Department of Applied Mathematics and Theoretical Physics (DAMTP) at the University of Cambridge, affiliated with the Quantum Fluids research group. His work focuses on theoretical and computational studies of quantum fluids, particularly exciton-polaritons in semiconductor microcavities and their interactions with electrons and photons. His research bridges condensed matter physics, quantum optics, and nanotechnology. Dr. Li's interdisciplinary interests also extend to pharmacology and clinical medicine, evidenced by collaborative studies on drug efficacy, drug-related problems in hospital settings, and guidelines for off-label drug use in ophthalmology. These studies address topics such as glucocorticoid therapy complications, proton pump inhibitor utilization, and anti-vascular endothelial growth factor treatments for ocular diseases. His quantum physics publications explore polariton scattering, Bose-Einstein condensates, and chiral edge states in quantum fluids. Recent medical studies analyze drug safety, self-monitoring in diabetes, and inappropriate medication use in elderly cardiac patients. These works highlight his dual contribution to fundamental physics research and applied clinical pharmacology. No academic awards or grants are explicitly stated in available records. He advises no known students but collaborates across disciplines in Cambridge and Chinese medical institutions. His research is conducted within the Quantum Fluids group at DAMTP, leveraging advanced theoretical models and computational simulations.

• Quantum Physics
• Condensed Matter Physics
• Theoretical Physics
• +۴ مورد دیگر

Matti Marklund is an Assistant Professor at the Bloomberg School of Public Health , Johns Hopkins University , with additional appointments at The George Institute for Global Health (Australia) and Uppsala University (Sweden). He holds a PhD in Food Science from the Swedish University of Agricultural Sciences (2012) and an MSc in Engineering Biotechnology from Umeå University (2007). His research focuses on nutrition and public health , particularly diet-disease relationships , cardiometabolic epidemiology , and food policy . Key areas include sodium and potassium intake , trans-fatty acids , dietary fat quality , and cost-effectiveness analysis of global health interventions. He has led studies on salt substitution , food pricing policies , and hypertension management . His 15 most recent publications (2025–2019) cover topics such as trans-fatty acid biomarkers in Nigeria , price elasticity of food in Australia , hypertension treatment modeling in India , and diabetes risk from fatty acid intake . These works integrate modeling , cohort studies , and systematic reviews across public health , cardiovascular medicine , and nutritional epidemiology . Scientific awards include: 2022 & 2021: Paul Dudley White International Scholar Award, American Heart Association 2017 & 2016: Dr. P Håkansson’s Foundation Research Award His work has been cited over 3,000 times and referenced in 25 policy documents (WHO, World Bank). He has collaborated with institutions in Kenya , Nigeria , India , and Bangladesh for global health interventions .

• Nutrition
• Public Health
• Cardiometabolic Epidemiology
• +۷ مورد دیگر

Prof. Pierre Jaïs serves as University Professor in Cardiology and Cardiac Electrophysiology at the University of Bordeaux and Head of the Electrophysiology Unit at Bordeaux University Hospital. He concurrently leads the Electrophysiology and Heart Modeling Institute (LIRYC) as CEO since 2021, driving innovation in cardiac rhythm disorder treatments through multidisciplinary research. His research revolutionized cardiac electrophysiology by identifying pulmonary veins as primary sources of atrial fibrillation, establishing pulmonary vein isolation as the global treatment standard. Current work focuses on pulsed field ablation—a non-thermal technique with potential to replace conventional ablation—and developing advanced imaging for precise arrhythmia targeting, reflecting his commitment to translating scientific discovery into clinical solutions. Analysis of recent publications (2017-2021) reveals dominant trends in pulsed field ablation optimization, comparative ablation techniques, and AI integration in cardiovascular imaging. These works consistently address atrial fibrillation treatment efficacy, safety profiles, and technological innovation, positioning him at the forefront of electrophysiology advancement. His distinguished contributions are recognized through prestigious awards including: 2019: Eli S. Gang Most Innovative Abstract Award (Heart Rhythm Society) 2018: Eric N. Prystowsky Lectureship Award 2012: Academy of Medicine Membership (Paris) 2009: Circulation Best Paper Award Multiple National Academy of Medicine honors Prof. Jaïs actively mentors electrophysiology trainees and secures substantial research funding, notably leading an EU-funded randomized trial comparing pulsed field versus thermal ablation. His LIRYC institute integrates cardiology, engineering, and computational expertise to accelerate therapeutic innovation. The LIRYC institute operates as a collaborative hub where clinicians, biomedical engineers, and data scientists develop next-generation electrophysiology tools. Current projects include real-time arrhythmia mapping systems, tissue-selective ablation protocols, and AI-driven predictive models for treatment personalization, fostering seamless translation from bench to bedside.

• Cardiac Arrhythmias
• Atrial Fibrillation
• Catheter Ablation
• +۶ مورد دیگر

Ruoqing Zhu is an Associate Professor in the Department of Statistics at the University of Illinois at Urbana-Champaign, with a primary appointment in the College of Liberal Arts & Sciences. He also serves as an inaugural member of the Carle Illinois College of Medicine, a Faculty Fellow at the National Center for Supercomputing Applications, and an affiliated researcher with the Carl R. Woese Institute for Genomic Biology and the Center for Genomic Diagnostics. His roles include PhD Program Director and Advisory Board member of Prenosis Inc. Dr. Zhu holds a Ph.D. in Biostatistics from the University of North Carolina at Chapel Hill (2013), an MA in Statistics from Bowling Green State University (2008), and dual B.S. degrees in Mathematics and Financial Engineering from Nanjing University (2006, 2005). His postdoctoral training was at Yale University’s Department of Biostatistics (2013–2015). His research focuses on developing statistical methods for decision-making in personalized medicine and reinforcement learning, addressing challenges such as model interpretability, high-dimensional data, and distributional shifts. Key areas include uncertainty quantification, causal inference, and applications in bioinformatics, nutrition, and infectious diseases. He co-teaches courses at Carle Illinois, including Data Science Project and Foundations: Molecules to Populations , and contributes to interdisciplinary initiatives like the Personalized Nutrition Initiative. His recent work emphasizes trustworthy AI in healthcare, including sepsis prediction tools, metabolomic analysis, and biomarker discovery. He is actively involved in translational research, bridging computational methods with clinical and public health applications.

• Biostatistics
• Machine Learning
• Personalized Medicine
• +۵ مورد دیگر

Dr. Vera Deneer is an Associate Professor of Clinical Pharmacology at the Utrecht Institute for Pharmaceutical Research (UIPS) within the Faculty of Science at Utrecht University, specializing in the Division of Pharmacoepidemiology and Clinical Pharmacology since 2019. She also serves as a hospital pharmacist and clinical pharmacologist at the University Medical Center Utrecht (UMC Utrecht) at the Department of Clinical Pharmacy since 2017. Dr. Deneer holds significant leadership positions including Vice-Chair of the Medicines Evaluation Board (MEB-CBG) since 2019 and Chair of the Dutch Pharmacogenetics Working Group (DPWG). Dr. Deneer received her PharmD from Utrecht University in 1991 and her PhD from Groningen University in 2003, with research focused on clinical pharmacology and pharmacokinetics of antiarrhythmic drugs in atrial fibrillation. She completed clinical training in hospital pharmacy in 1994 and clinical pharmacology training in 1998. Prior to her current positions, she served as Head of the Pharmacogenetics, Pharmaceutical and Toxicological Laboratory at St. Antonius Hospital, Nieuwegein/Utrecht from 1998 to 2017. Her research focuses on personalized medicine through the study of biomarkers including genetic variants, patient characteristics, and clinical parameters to optimize drug treatment efficacy and safety. Her work primarily targets cardiovascular disease, lung cancer, and immune-mediated inflammatory diseases. She also investigates clinical reasoning and decision-making by pharmacists to improve medication management in clinical practice. Dr. Deneer serves as principal investigator for multiple research projects funded by The Netherlands Organisation for Health Research and Development. Dr. Deneer's recent publications demonstrate her leadership in pharmacogenetics guidelines development, with numerous Dutch Pharmacogenetics Working Group (DPWG) guidelines published in 2023-2025 covering gene-drug interactions for various medication classes including antidepressants, antipsychotics, anti-epileptics, and cardiovascular medications. Her work spans both clinical implementation research and educational aspects of pharmacy practice. Among her significant appointments, Dr. Deneer serves as Vice-Chair of the Medicines Evaluation Board (MEB-CBG) and Chair of the Dutch Pharmacogenetics Working Group (DPWG). She previously chaired a medical research ethics committee from 2012-2017 and serves on multiple national and hospital committees related to pharmacotherapy and drug safety. Dr. Deneer has been actively involved in mentoring pharmacy students and professionals, with recent publications focusing on clinical decision-making education for pharmacists. Her work bridges the gap between pharmacogenetic research and clinical implementation, with particular emphasis on optimizing drug treatment strategies for individual patients while minimizing adverse drug reactions.

• Pharmacogenetics
• Clinical Pharmacology
• Personalized Medicine
• +۴ مورد دیگر

Professor Peter Watkinson serves as Professor of Intensive Care Medicine at the University of Oxford and is an NHS consultant in intensive care at the Oxford University Hospitals NHS Foundation Trust. He leads the Critical Care Research Group based at the Kadoorie Centre for Critical Care Research & Education at the John Radcliffe Hospital, Oxford. His work bridges clinical practice with academic research in the field of critical care medicine through the Nuffield Department of Clinical Neurosciences. Professor Watkinson's research primarily focuses on the identification of deteriorating patients in hospital settings. His work encompasses: Design and implementation of studies on wearable monitoring devices Exploration of non-contact monitoring technologies Analysis of standard electronically-recorded patient descriptors Pattern recognition in vital signs data to predict clinical deterioration Development of electronic monitoring systems Application of human factors techniques for technology integration in healthcare Assessment of long-term effects of critical illnesses on patient quality of life The Critical Care Research Group maintains a strong collaborative link with the University of Oxford Institute of Biomedical Engineering. Using data collected from thousands of patients' vital signs both in Oxford and elsewhere, the multi-disciplinary team investigates patterns that precede and predict clinical deterioration in hospitalized patients. Recent publications indicate a strong focus on early warning scores, patient monitoring technologies, and the application of machine learning approaches to critical care data. Professor Watkinson's research output demonstrates consistent productivity with numerous 2024-2025 publications spanning systematic reviews of early warning systems, development of novel monitoring technologies, and analytical approaches to predicting patient deterioration. His work frequently employs rigorous methodology including systematic reviews, meta-analyses, and innovative study designs to address critical questions in intensive care medicine. As leader of the Critical Care Research Group, Professor Watkinson oversees a multi-disciplinary team investigating vital sign patterns and developing predictive algorithms that have direct clinical applications. The group's research has significant implications for improving patient safety through earlier recognition of clinical deterioration and more effective resource allocation in hospital settings.

• Critical Care Medicine
• Intensive Care
• Patient Deterioration Monitoring
• +۶ مورد دیگر

Bjørn Olav Åsvold, MD, PhD, is a Professor of Medicine (Epidemiology) and Center leader at the HUNT Centre for Molecular and Clinical Epidemiology (HUNT MCE), Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU). He also serves as a Consultant at the Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital. His research spans epidemiology, genetics, and clinical medicine. MD, Norwegian University of Science and Technology, 2001 PhD, Norwegian University of Science and Technology, 2008 Specialist in internal medicine, 2014 Specialist in endocrinology, 2015 Åsvold's research focuses on thyroid dysfunction and diabetes , investigating their interplay with cardiometabolic diseases and pregnancy complications . He utilizes Mendelian randomization studies to explore causal relationships between genetic factors and health outcomes, including sleep traits , autoimmune thyroid disease , and kidney function . His work also addresses global health issues like obesity in Nepal and diabetic complications in Norway. Recent publications highlight his contributions to understanding hip fracture risk prediction , cardiovascular implications of sleep patterns , and genetic determinants of trace elements . Åsvold's collaborations span multiple international institutions, including the HUNT Study and HUNT MCE in Norway.

• Thyroid dysfunction
• Diabetes
• Pregnancy complications and cardiovascular risk
• +۱ مورد دیگر

Dr. Michael Stevens is a Senior Lecturer at University of New South Wales (UNSW) Canberra , where he focuses on advanced manufacturing and biomedical device control systems . His work bridges digital manufacturing for SMEs with smart artificial heart technologies , emphasizing industry collaboration and translational research. Specializes in physiological control systems for rotary blood pumps Develops unobtrusive fall detection systems for dementia patients Leads international projects on total artificial heart development Education : B.Eng (Medical - First Class Honours), Queensland University of Technology (2010) PhD in Physiological Control for Biventricular Assist Devices, University of Queensland (2014) Research Trends show consistent focus on: Machine learning for biomedical diagnostics (2018–2025) mmWave radar and thermal sensors in patient monitoring (2021–2024) Computational fluid dynamics in artificial heart modeling (2016–2024) Physiological control algorithms for rotary blood pumps (2011–2025) Scientific Awards : UNSW Scientia Education Award (2021) for contextual teaching Heart Foundation Runner-up for "Smart Artificial Hearts" pitch (2021) ARC PGC Supervisor Award (2017) for mentoring Grants & Supervision : Holds over $6 million in competitive funding including MRFF and ARC grants. Currently supervises 4 PhD students while maintaining industry partnerships with VitalCare and BiVACOR. Labs & Facilities : Works across UNSW Engineering labs and Graduate School of Biomedical Engineering platforms, including mock circulation loops and high-performance computing clusters for CFD simulations.

• Biomedical Engineering
• Advanced Manufacturing
• Digital Manufacturing
• +۶ مورد دیگر

Zubin Punthakee is an Associate Professor in the Department of Endocrinology & Metabolism within the Faculty of Medicine at McMaster University. His scholarly activity spans over 30 years with 97 publications in the last 10 years, demonstrating sustained research productivity in diabetes, endocrine disorders, and metabolic health. Dr. Punthakee's research interests focus on several key areas in endocrinology and diabetes care. He has made significant contributions to understanding type 2 diabetes remission through metabolic interventions, transition care for adolescents with type 1 diabetes moving to adult care systems, hypoparathyroidism management and skeletal health outcomes, and health disparities among South Asian populations. His work often involves large-scale clinical trials, registry-based research (particularly the Canadian National Hypoparathyroidism Registry), and implementation science approaches to improve diabetes care delivery. Analysis of his recent publications reveals a strong focus on diabetes remission strategies, transition care quality improvement, and skeletal complications of endocrine disorders. His work bridges clinical endocrinology with health services research, often examining how to translate evidence into practice through audit and feedback mechanisms and structured transition programs. Dr. Punthakee has been actively involved in numerous clinical trials including the REMIT-iGlarLixi trial examining diabetes remission, and has contributed to major clinical practice guidelines for diabetes management across the lifespan. His work with the Canadian National Hypoparathyroidism Registry has produced multiple publications characterizing the etiology, clinical manifestations, and management strategies for hypoparathyroidism. His research frequently addresses health disparities, particularly among South Asian populations in Canada, examining factors like vaccine effectiveness, dietary patterns, and cardiovascular risk. This work demonstrates his commitment to addressing health equity through rigorous clinical research.

• Endocrinology
• Diabetes Research
• Metabolism
• +۵ مورد دیگر

Ross Koppel is an Adjunct Professor of Sociology with expertise in healthcare information technology, medication errors, and ethics in social research. His work explores the intersection of technology and societal impacts, focusing on data governance, clinical workflows, and human factors in health IT systems. Research Interests Context-sensitive understanding of medication errors Societal implications of clinical data sharing Ethical challenges in AI and informatics Healthcare cost analysis Scientific Awards Fellow of the American College of Medical Informatics (FACMI)

• Healthcare Information Technology
• Medication Errors
• Technology in Society
• +۲ مورد دیگر

Alexandre Almorad is a Clinical Professor affiliated with the Faculty of Medicine and Pharmacy at Vrije Universiteit Brussel (UZB). His research focuses on cardiac arrhythmias, particularly Brugada Syndrome and Atrial Fibrillation, with expertise in catheter ablation techniques and electrophysiological diagnostics. He has contributed to over 100 peer-reviewed articles and holds the Paul Dudley White International Scholar Award-Belgium (2023). Research interests include hybrid ablation therapies, pulsed field ablation technologies, and genetic correlates of cardiac arrhythmias. His work integrates clinical outcomes with innovative diagnostic approaches, such as 2D speckle-tracking echocardiography and right ventricular outflow tract analysis. Key Awards: Paul Dudley White International Scholar Award-Belgium (2023). Collaborations: Multicenter studies on novel catheter designs and SCN5A mutation correlations. His publications emphasize translational research bridging surgical and electrophysiological interventions for arrhythmia management.

• Brugada Syndrome
• Atrial Fibrillation
• Cardiac Arrhythmias
• +۳ مورد دیگر

Eva Gerdts is a Professor at the Clinical Institute 2, University of Bergen, and is affiliated with Haukeland University Hospital. She is a Member of the Norwegian Academy of Sciences and leads the Bergen Hypertension and Cardiac Dynamics Group. Her work is central to the Center for Research on Heart Disease in Women, established in 2020 with support from the Heart Foundation, Bergen Women's Health Association, and the Grieg Foundation. University: University of Bergen Affiliation: Clinical Institute 2 Research Group: Hypertension and Cardiac Dynamics Center: Center for Research on Heart Disease in Women Email: eva.gerdts@uib.no Her research focuses on heart disease in women , particularly as influenced by hypertension, aortic valve stenosis, obesity, and autoimmune diseases. She investigates sex-specific differences in cardiac strain, arterial stiffness, and myocardial remodeling. Her work emphasizes how male-based data cannot be extrapolated to women, advocating for gender-specific cardiovascular guidelines. Her recent publications span population studies like the Tromsø and Hordaland Health Surveys, clinical trials, and international collaborations. Key trends include sex differences in hypertension outcomes , cardiac effects of bariatric surgery , cryptogenic stroke in young adults , and inflammatory markers in autoimmune diseases . Her research integrates echocardiography, longitudinal data, and public health implications. Scientific recognition includes: Member of the Norwegian Academy of Sciences National Heart Association's Heart Research Prize 2022 She supervises multiple PhD and Master’s students, including Ester Kringeland, Sahrai Saeed, and Arleen Aune. She leads the PhD course NORHEART901 in Cardiovascular Imaging and teaches in medical education on hypertension, cardiac ultrasound, and women's heart health. Her research is supported by large-scale population studies and clinical collaborations, particularly through the NOR-SYS and SECRETO projects. She also organizes professional education on valvular disease and dyspnea. She leads or collaborates with several research teams: Bergen Hypertension and Cardiac Dynamics Group Center for Research on Heart Disease in Women NOR-SYS (Norwegian Stroke in the Young Study) SECRETO (Searching for Explanations for Cryptogenic Stroke in the Young) FATCOR Study (Fitness, Adiposity, and Cardiovascular Risk)

• Cardiovascular Medicine
• Hypertension
• Heart Disease in Women
• +۷ مورد دیگر